Literature DB >> 15932511

Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection.

D Sansonno1, G Lauletta, M Montrone, G Grandaliano, F P Schena, F Dammacco.   

Abstract

The role of hepatitis C virus (HCV) in the production of renal injury has been extensively investigated, though with conflicting results. Laser capture microdissection (LCM) was performed to isolate and collect glomeruli and tubules from 20 consecutive chronically HCV-infected patients, namely 6 with membranoproliferative glomerulonephritis, 4 with membranous glomerulonephritis, 7 with focal segmental glomerulosclerosis and 3 with IgA-nephropathy. RNA for amplification of specific viral sequences was provided by terminal continuation methodology and compared with the expression profile of HCV core protein. For each case two glomeruli and two tubular structures were microdissected and processed. HCV RNA sequences were demonstrated in 26 (65%) of 40 glomeruli, but in only 4 (10%) of the tubules (P < 0.05). HCV core protein was concomitant with viral sequences in the glomeruli and present in 31 of the 40 tubules. HCV RNA and/or HCV core protein was found in all four disease types. The immunohistochemical picture of HCV core protein was compared with the LCM-based immunoassays of the adjacent tissue sections. Immune deposits were detected in 7 (44%) of 16 biopsy samples shown to be positive by extraction methods. The present study indicates that LCM is a reliable method for measuring both HCV RNA genomic sequences and HCV core protein in kidney functional structures from chronically HCV-infected patients with different glomerulopathies and provides a useful baseline estimate to define the role of HCV in the production of renal injury. The different distribution of HCV RNA and HCV-related proteins may reflect a peculiar 'affinity' of kidney microenvironments for HCV and point to distinct pathways of HCV-related damage in glomeruli and tubules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932511      PMCID: PMC1809381          DOI: 10.1111/j.1365-2249.2005.02778.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia.

Authors:  D Sansonno; V Cornacchiulo; A R Iacobelli; R Di Stefano; M Lospalluti; F Dammacco
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

2.  Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.

Authors:  R Thomssen; S Bonk; A Thiele
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

3.  DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2.

Authors:  Pierre-Yves Lozach; Hugues Lortat-Jacob; Agnès de Lacroix de Lavalette; Isabelle Staropoli; Steven Foung; Ali Amara; Corinne Houles; Frank Fieschi; Olivier Schwartz; Jean-Louis Virelizier; Fernando Arenzana-Seisdedos; Ralf Altmeyer
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

4.  Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; L Nisi; P Gatti; F Pesola; N Pansini; F Dammacco
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

5.  Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay.

Authors:  D Sansonno; G Lauletta; F Dammacco
Journal:  J Viral Hepat       Date:  2004-01       Impact factor: 3.728

6.  Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells.

Authors:  Ramó Bataller; Yong-Han Paik; Jeffrey N Lindquist; John J Lemasters; David A Brenner
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay.

Authors:  K K Young; R M Resnick; T W Myers
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Biophysical characterization of hepatitis C virus core protein: implications for interactions within the virus and host.

Authors:  Meghan Kunkel; Stanley J Watowich
Journal:  FEBS Lett       Date:  2004-01-16       Impact factor: 4.124

9.  Fcgamma receptor-like activity of hepatitis C virus core protein.

Authors:  Patrick Maillard; Jean-Pierre Lavergne; Sophie Sibéril; Grazyna Faure; Farzin Roohvand; Stephane Petres; Jean Luc Teillaud; Agata Budkowska
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

Review 10.  Viral hepatitis C.

Authors:  Thierry Poynard; Man-Fung Yuen; Vlad Ratziu; Ching Lung Lai
Journal:  Lancet       Date:  2003-12-20       Impact factor: 79.321

View more
  26 in total

1.  Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010.

Authors:  Robert D Allison; Xin Tong; Anne C Moorman; Kathleen N Ly; Loralee Rupp; Fujie Xu; Stuart C Gordon; Scott D Holmberg
Journal:  J Hepatol       Date:  2015-05-01       Impact factor: 25.083

Review 2.  Secondary IgA nephropathy.

Authors:  Manish K Saha; Bruce A Julian; Jan Novak; Dana V Rizk
Journal:  Kidney Int       Date:  2018-05-24       Impact factor: 10.612

3.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 4.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

5.  Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis.

Authors:  Qinglong Jin; Yuki Moritoki; Ana Lleo; Koichi Tsuneyama; Pietro Invernizzi; Hitoshi Moritoki; Kentaro Kikuchi; Zhe-Xiong Lian; Gideon M Hirschfield; Aftab A Ansari; Ross L Coppel; M Eric Gershwin; Junqi Niu
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

6.  Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin.

Authors:  Moutaz Derbala; Fatma-M Shebl; Awad Rashid; Aliaa Amer; Abdulbari Bener
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

7.  Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection.

Authors:  Sanjaya Kumar Satapathy; Chandra Sekhar Lingisetty; Susan Williams
Journal:  Hepatol Int       Date:  2011-06-23       Impact factor: 6.047

Review 8.  Vasculitis: determinants of disease patterns.

Authors:  Gary S Hoffman; Leonard H Calabrese
Journal:  Nat Rev Rheumatol       Date:  2014-06-17       Impact factor: 20.543

9.  Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway.

Authors:  Holger Hägele; Ramanjaneyulu Allam; Rahul D Pawar; Christoph A Reichel; Fritz Krombach; Hans-Joachim Anders
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Association of hepatitis C virus infection with prevalence and development of kidney disease.

Authors:  Sharon M Moe; A J Pampalone; Susan Ofner; Marc Rosenman; Evgenia Teal; Siu L Hui
Journal:  Am J Kidney Dis       Date:  2008-04-28       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.